Literature DB >> 19549617

The Lausanne recommendations: a Dutch experience.

B Bessem1, F P Groot, W Nieuwland.   

Abstract

OBJECTIVE: This study presents the results of 28 months of preparticipation cardiovascular screening using the Lausanne recommendations, which include a personal and family history, physical examination and electrocardiogram (ECG).
DESIGN: From January 2006 to April 2008 the data of the Lausanne screenings carried out at the University Centre of Sports Medicine in Groningen were collected. PARTICIPANTS: 825 cardiovascular screenings were performed of which 397 were excluded. Exclusion criteria were age under 12 or over 35 years, multiple screenings (only the first was included) and known cardiovascular disease. MAIN OUTCOME MEASURES: Negative screening result, (false) positive screening result, medical consumption and number needed to screen.
RESULTS: A total of 371 (87%) athletes had a negative screening result. Fifty-five athletes (13%) underwent additional (stage 2) testing and seven (1.6%) further (stage 3) testing. Only 27 athletes (6.3%) were referred for additional testing based only on abnormalities of their ECG. Forty-seven athletes (11%) had a false-positive screening result. Ten athletes (2%) had a positive screening result and three (0.7%) were ultimately restricted from sports participation. Stage 2 medical consumption was 62%, 20% and 18% for one, two and three or more additional tests, respectively. Stage 3 medical consumption was 1.6%. The number of athletes needed to screen to find a single athlete with a potentially lethal cardiovascular disease was 143.
CONCLUSION: This study found that when the Lausanne recommendations are implemented in The Netherlands, screening results resemble those found in previous studies. The number of athletes needed to screen to detect one athlete with a potentially lethal cardiovascular disease is also within an acceptable range.

Entities:  

Mesh:

Year:  2009        PMID: 19549617     DOI: 10.1136/bjsm.2008.056929

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  7 in total

1.  Reliability and validity of clinician ECG interpretation for athletes.

Authors:  Charles Magee; Joshua Kazman; Mark Haigney; Ralph Oriscello; Kent J DeZee; Patricia Deuster; Patrick Depenbrock; Francis G O'Connor
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-02-12       Impact factor: 1.468

2.  Interassociation Consensus Statement on Cardiovascular Care of College Student-Athletes.

Authors:  Brian Hainline; Jonathan Drezner; Aaron Baggish; Kimberly G Harmon; Michael S Emery; Robert J Myerburg; Eduardo Sanchez; Silvana Molossi; John T Parsons; Paul D Thompson
Journal:  J Athl Train       Date:  2016-04-25       Impact factor: 2.860

3.  Influence of type and duration of training on the presence of an abnormal ECG in high-performance athletes.

Authors:  Geoffrey Verrall; Angus Hains; Bronte Ayres; Richard Hillock
Journal:  Heart Asia       Date:  2019-03-19

4.  The Validity of Adding ECG to the Preparticipation Screening of Athletes An Evidence Based Literature Review.

Authors:  A Alattar; N Maffulli
Journal:  Transl Med UniSa       Date:  2014-12-19

5.  Prevalence of Cardiovascular Disorders Among Iranian Elite Athletes.

Authors:  Shahin Salehi; Farhad Moradi Shahpar; Gholamreza Norouzi; Farshad Ghazalian; Mehrshad Poursaid Esfehani; Amir Hosein Abedi Yekta
Journal:  Asian J Sports Med       Date:  2016-05-11

Review 6.  Pre-participation musculoskeletal and cardiac screening of male athletes in the United arab emirates.

Authors:  A Alattar; S Ghani; N Mahdy; H Hussain; N Maffulli
Journal:  Transl Med UniSa       Date:  2014-04-24

7.  ECG evaluation in 11 949 Italian teenagers: results of screening in secondary school.

Authors:  Massimo Mancone; Viviana Maestrini; Antonio Fusto; Francesco Adamo; Paola Scarparo; Alessandra D'Ambrosi; Alessandra Cinque; Maria Chiara Gatto; Nicolò Salvi; Gianluca Agnes; Mariateresa Pucci; Lucia Ilaria Birtolo; Laura Marruncheddu; Igino Genuini; Claudio De Lazzari; Paolo Severino; Giuseppe Giunta; Carlo Lavalle; Danilo Alunni Fegatelli; Annarita Vestri; Francesco Fedele
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2022-02-01       Impact factor: 2.160

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.